AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -64.7% | 7,428 | 0.0% | 0.00% | – |
| Q4 2021 | $17,000 | -19.0% | 7,428 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -25.0% | 7,428 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | +12.0% | 7,428 | 0.0% | 0.00% | – |
| Q1 2021 | $25,000 | +19.0% | 7,428 | 0.0% | 0.00% | – |
| Q4 2020 | $21,000 | +10.5% | 7,428 | 0.0% | 0.00% | – |
| Q3 2020 | $19,000 | -81.0% | 7,428 | 0.0% | 0.00% | – |
| Q2 2020 | $100,000 | +194.1% | 7,428 | +66.3% | 0.00% | – |
| Q1 2020 | $34,000 | +21.4% | 4,466 | 0.0% | 0.00% | – |
| Q4 2019 | $28,000 | -31.7% | 4,466 | -46.9% | 0.00% | – |
| Q2 2019 | $41,000 | -40.6% | 8,418 | 0.0% | 0.00% | – |
| Q1 2019 | $69,000 | +53.3% | 8,418 | 0.0% | 0.00% | – |
| Q4 2018 | $45,000 | +9.8% | 8,418 | +80.1% | 0.00% | – |
| Q3 2018 | $41,000 | -12.8% | 4,675 | 0.0% | 0.00% | – |
| Q2 2018 | $47,000 | +4.4% | 4,675 | 0.0% | 0.00% | – |
| Q1 2018 | $45,000 | -34.8% | 4,675 | 0.0% | 0.00% | – |
| Q4 2017 | $69,000 | – | 4,675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |